Literature DB >> 1740106

A novel complex between the p65 subunit of NF-kappa B and c-Rel binds to a DNA element involved in the phorbol ester induction of the human urokinase gene.

S K Hansen1, C Nerlov, U Zabel, P Verde, M Johnsen, P A Baeuerle, F Blasi.   

Abstract

The NF-kappa B subunits, p50 and p65, have extensive sequence homology with the c-rel proto-oncogene and the Drosophila morphogen dorsal. It has recently been shown that in vitro translated c-Rel can bind to DNA and form a complex with p50. However, the conditions for DNA binding of c-Rel in vivo and its DNA sequence specificity have not been established. Here we report the identification a novel heterodimeric complex that binds to a kappa B-like, phorbol ester (TPA) responsive DNA sequence, 5'-GGGAAAGTAC-3', in the 5' flanking region of the human urokinase (uPA) gene. This sequence was shown to bind two protein complexes, LC and UC. LC was indistinguishable from NF-kappa B as it reacted with antibodies recognizing the p50 subunit of NF-kappa B, and was shown by UV crosslinking to contain the p50 and p65 subunits of NF-kappa B. UC, on the other hand, strongly reacted with anti-v-Rel, but not with the anti-p50 antibodies, and was shown by crosslinking to contain 75 kDa and 85 kDa protein-DNA adducts. The 75 kDa and the 85 kDa adducts could be immunoprecipitated only by anti-p65 and anti-c-Rel antibodies, respectively, showing that c-Rel formed a heterodimer with p65. Both protein complexes were present in inactive forms in HeLa cell cytosol, and their nuclear translocation was induced by TPA. DNA binding of UC and LC could, furthermore, be inhibited by I kappa B-alpha.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1740106      PMCID: PMC556441          DOI: 10.1002/j.1460-2075.1992.tb05043.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  51 in total

1.  Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-kappa B.

Authors:  S M Ruben; P J Dillon; R Schreck; T Henkel; C H Chen; M Maher; P A Baeuerle; C A Rosen
Journal:  Science       Date:  1991-03-22       Impact factor: 47.728

2.  c-rel activates but v-rel suppresses transcription from kappa B sites.

Authors:  J Inoue; L D Kerr; L J Ransone; E Bengal; T Hunter; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

Review 3.  The urokinase receptor and regulation of cell surface plasminogen activation.

Authors:  F Blasi; N Behrendt; M V Cubellis; V Ellis; L R Lund; M T Masucci; L B Møller; D P Olson; N Pedersen; M Ploug
Journal:  Cell Differ Dev       Date:  1990-12-02

4.  The v-rel oncogene encodes a kappa B enhancer binding protein that inhibits NF-kappa B function.

Authors:  D W Ballard; W H Walker; S Doerre; P Sista; J A Molitor; E P Dixon; N J Peffer; M Hannink; W C Greene
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

5.  DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide.

Authors:  G P Nolan; S Ghosh; H C Liou; P Tempst; D Baltimore
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

6.  The v-rel and c-rel proteins exist in high molecular weight complexes in avian and murine cells.

Authors:  T Kochel; J F Mushinski; N R Rice
Journal:  Oncogene       Date:  1991-04       Impact factor: 9.867

7.  A family of constitutive C/EBP-like DNA binding proteins attenuate the IL-1 alpha induced, NF kappa B mediated trans-activation of the angiotensinogen gene acute-phase response element.

Authors:  A R Brasier; D Ron; J E Tate; J F Habener
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

8.  Inhibition of transcription factors belonging to the rel/NF-kappa B family by a transdominant negative mutant.

Authors:  F Logeat; N Israël; R Ten; V Blank; O Le Bail; P Kourilsky; A Israël
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

9.  Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos.

Authors:  A P Sappino; J Huarte; D Belin; J D Vassalli
Journal:  J Cell Biol       Date:  1989-11       Impact factor: 10.539

10.  The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B.

Authors:  M L Schmitz; P A Baeuerle
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  47 in total

1.  Nuclear factor-kappaB (NF-kappaB) regulates proliferation and branching in mouse mammary epithelium.

Authors:  D M Brantley; C L Chen; R S Muraoka; P B Bushdid; J L Bradberry; F Kittrell; D Medina; L M Matrisian; L D Kerr; F E Yull
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

2.  Importance of interleukin-1 and interleukin-1 receptor antagonist in short-term glucose sensor function in vivo.

Authors:  Ulrike Klueh; Zenghe Liu; Ben Feldman; Don Kreutzer
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

3.  Rickettsia rickettsii infection of cultured human endothelial cells induces NF-kappaB activation.

Authors:  L A Sporn; S K Sahni; N B Lerner; V J Marder; D J Silverman; L C Turpin; A L Schwab
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

4.  CD28 mediates a potent costimulatory signal for rapid degradation of IkappaBbeta which is associated with accelerated activation of various NF-kappaB/Rel heterodimers.

Authors:  E W Harhaj; S B Maggirwar; L Good; S C Sun
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

5.  Inhibition of NF-kappa B-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAI-1.

Authors:  U Reuning; O Wilhelm; T Nishiguchi; L Guerrini; F Blasi; H Graeff; M Schmitt
Journal:  Nucleic Acids Res       Date:  1995-10-11       Impact factor: 16.971

6.  Structural and functional characterization of the promoter regions of the NFKB2 gene.

Authors:  L Lombardi; P Ciana; C Cappellini; D Trecca; L Guerrini; A Migliazza; A T Maiolo; A Neri
Journal:  Nucleic Acids Res       Date:  1995-06-25       Impact factor: 16.971

7.  Minnelide reduces tumor burden in preclinical models of osteosarcoma.

Authors:  Sulagna Banerjee; Venugopal Thayanithy; Veena Sangwan; Tiffany N Mackenzie; Ashok K Saluja; Subbaya Subramanian
Journal:  Cancer Lett       Date:  2013-03-14       Impact factor: 8.679

8.  Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a kappa B-like site.

Authors:  P A Oeth; G C Parry; C Kunsch; P Nantermet; C A Rosen; N Mackman
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

9.  CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells.

Authors:  Bryan C Barnhart; Patrick Legembre; Eric Pietras; Concetta Bubici; Guido Franzoso; Marcus E Peter
Journal:  EMBO J       Date:  2004-07-22       Impact factor: 11.598

10.  Two distinct NF-kappa B complexes differing in their larger subunit bind the E-selectin promoter kappa B element.

Authors:  R Hooft van Huijsduijnen; R Pescini; J F DeLamarter
Journal:  Nucleic Acids Res       Date:  1993-08-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.